JPX Equity Snapshot
4565 Weekly Equity Report
Nxera Pharma Co., Ltd.
What the company does
Nxera Pharma Co., Ltd. operates as a biopharmaceutical company, engages in drug discovery and development in Japan, the United States, Germany, Switzerland, Bermuda, the United Kingdom, and internationally. The company offers NxWave, a GPCR-targeted structure-based drug discovery platform; PIVLAZ for the cerebral vasospasm, vasospasm-related cerebral infarction, and cerebral ischemic symptoms after aSAH; and QUVIVIQ for insomnia. It develops NBI-1117568, an muscarinic M4 agonist in phase 3 trial for schizophrenia, dementia and other neuropsychiatric disorders; ORX750, an OX2 agonist for narcolepsy, idiopathic hypersomnia, and other sleep-wake disorders; NBI-1117570, a dual muscarinic M1/M4 agonist; and HTL0039732, an …
What the weekly tape is saying
4565 closed the latest completed week at 983.0 JPY. The 4-week return is -16.1% and the 12-week return is 11.8%. Trend Signal is active, Market Dynamics is 0.73. Setup signature: Risk-first tape with a 32/100 composite read.
A compressed read of the whole setup
The radar blends trend persistence, momentum, Market Dynamics, Relative Strength, volume confirmation, and risk control into one weekly cockpit.
Scoreboard
16-week signal tape
Price, Trend Line, and Fair Value
Weekly price context with the latest close, trend position, Fair Value gap, drawdown, and 52-week range location.
52-week price path
Price map
- Trend Line
- 928.2 JPY
- Vs Trend Line
- 5.9%
- Fair Value
- 1,201 JPY
- Vs Fair Value
- -18.1%
- 52W High
- 1,247 JPY
- 52W Low
- 723.0 JPY
- Drawdown
- -21.2%
- Range Position
- 49.6%
Returns and trend persistence
Return windows separate the latest week from short-term and medium-term follow-through.
Return windows
Trend read
- Active Streak
- 9 weeks
- 52W Active Weeks
- 20
- 52W Active Breadth
- 38.5%
- Sector Scope
- JP Healthcare
- Sector Rank
- 108 of 223
- Sector Percentile
- 51.8%
Sector and industry pulse
Peer breadth helps separate a stock-specific move from a broader group rotation.
JP Healthcare
- Tracked Peers
- 100
- 4W Rank
- 91 of 100
- Avg 1W
- -1.3%
- Avg 4W
- -3.4%
- Trend Breadth
- 27.0%
- Positive MD
- 28.0%
JP Biotechnology
- Tracked Peers
- 48
- 4W Rank
- 24 of 48
- Avg 1W
- -6.1%
- Avg 4W
- -16.7%
- Trend Breadth
- 12.5%
- Positive RS
- 2.1%
Pressure, Relative Strength, and expectation
Market Dynamics and Relative Strength show whether buying pressure and relative leadership are confirming the price move.
Dynamics path
Signal state
- Market Dynamics
- 0.73
- 4W MD Change
- -46.8%
- Relative Strength
- -19.36
- 4W RS Change
- -15038.8%
- Expectation
- Undecided
- Probability
- 46.44%
Participation and confirmation
Volume tells us whether the latest weekly move is being confirmed by unusual participation.
52-week volume profile
Volume map
- Latest Volume
- 4.3M
- 13W Average
- 5.0M
- 52W Average
- 4.0M
- Vs 13W
- 0.9x
- Vs 52W
- 1.1x
Volatility, downside weeks, and return shape
A compact risk profile shows whether the move is steady, volatile, or being driven by sharp one-week jumps.
26-week return distribution
Risk map
- 13W Volatility
- 7.7%
- 52W Volatility
- 6.0%
- Upside Weeks
- 25
- Downside Weeks
- 26
- Downside Breadth
- 50.0%
- Avg Gain / Loss
- 5.0% / -4.2%
Classification, opportunities, risks, and watch points
Top-level read across company classification, constructive evidence, caution points, and the next things that matter.
Classification
- Exchange
- JPX
- Country
- JP
- Sector
- Healthcare
- Industry
- Biotechnology
- Currency
- JPY
- Market Cap
- 97.9B
Opportunity signals
- Trend Signal is active with a 9-week active streak.
- Price is above the Trend Line, keeping the weekly tape constructive.
- Market Dynamics is positive on the latest completed week.
Risk signals
- Price is below Fair Value, so the market is still discounting the latest tape.
- The share remains more than 20% below its 52-week high.
Watch next
- Trend Line remains the key weekly regime level.
- Market Dynamics is the pressure gauge to monitor for confirmation or fade.
- A volume ratio above 1.5x would show stronger participation in the next move.
Recent completed weeks
The latest weekly rows behind the report snapshot.
| Week | Close | Return | Trend | Fair Value | MD | RS | Volume | Signal |
|---|---|---|---|---|---|---|---|---|
| 12 Jun 2026 | 983.0 JPY | -1.3% | 928.2 JPY | 1,201 JPY | 0.73 | -19.36 | 4.3M | On |
| 5 Jun 2026 | 996.0 JPY | -6.7% | 924.2 JPY | 1,213 JPY | 1.17 | -19.77 | 5.8M | On |
| 29 May 2026 | 1,067 JPY | -5.2% | 917.0 JPY | 1,226 JPY | 1.53 | -14.56 | 4.5M | On |
| 22 May 2026 | 1,125 JPY | -4.0% | 911.3 JPY | 1,238 JPY | 1.45 | -6.41 | 4.1M | On |
| 15 May 2026 | 1,172 JPY | 0.4% | 906.0 JPY | 1,251 JPY | 1.37 | 0.13 | 6.2M | On |
| 8 May 2026 | 1,167 JPY | 22.6% | 899.2 JPY | 1,262 JPY | 1.26 | -2.64 | 6.5M | On |
| 1 May 2026 | 952.0 JPY | -1.7% | 893.1 JPY | 1,272 JPY | 1.16 | -16.70 | 2.9M | On |
| 24 Apr 2026 | 968.0 JPY | -4.4% | 893.9 JPY | 1,284 JPY | 1.40 | -16.37 | 4.4M | On |
| 17 Apr 2026 | 1,013 JPY | -0.8% | 894.5 JPY | 1,295 JPY | 1.30 | -11.39 | 4.6M | On |
| 10 Apr 2026 | 1,021 JPY | 1.6% | 894.9 JPY | 1,306 JPY | 1.04 | -8.90 | 4.1M | Off |
| 3 Apr 2026 | 1,005 JPY | 11.0% | 893.7 JPY | 1,316 JPY | 0.93 | -4.25 | 11.3M | Off |
| 27 Mar 2026 | 905.0 JPY | 3.0% | 893.2 JPY | 1,325 JPY | 0.73 | -14.57 | 3.2M | Off |
| 20 Mar 2026 | 879.0 JPY | -5.3% | 893.9 JPY | 1,334 JPY | 0.76 | -17.67 | 2.6M | Off |
| 13 Mar 2026 | 928.0 JPY | 2.5% | 896.2 JPY | 1,342 JPY | 0.87 | -14.43 | 4.8M | Off |